Combined synopsis and solicitation, total small business set-aside
One (1) Automated Dry Heat Flow Through System with 8 Diffusion cells
75F40125Q00397
Food and Drug Administration, Food and Drug Administration. Analytical Laboratory Instrument Manufacturing.
Response deadline
September 9, 2025 at 11:00 AM EDT
Closed 373 days ago. Posted August 30, 2025. Scheduled to archive September 24, 2025.
Description
As published on SAM.gov.
The U.S. Food and Drug Administration's (FDA) OPQ/OPQR is requesting the acquisition of one (1) Automated Dry Heat Flow Through System with 8 Diffusion cells (or equivalent). This Automated Dry Heat Flow Through System with 8 Diffusion cells will be used to perform in vitro diffusion studies using flow through cell assembly to check the drug release and permeation across synthetic and biological barriers. This Automated Dry Heat Flow Through System with 8 Diffusion cells and these diffusion studies will provide valuable information regarding safety, performance, and quality of transdermal and drug products and support CDER’s mission critical missions.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 30, 2025
Combined synopsis and solicitation
Due September 9, 2025 at 11:00 AM EDT. SAM.gov, notice c0510625fff74730b3caaf2b156af084
Points of contact
- Sarah Hussainsarah.hussain@fda.hhs.gov